Literature DB >> 10433109

The role of surgery in low grade gliomas.

J Bampoe1, M Bernstein.   

Abstract

Several prognostic factors appear to be more important than treatment factors in determining the outcome of patients with low grade glioma. The role of surgery in establishing a histological diagnosis or in relieving neurological deficit is well established. The role of surgery in prolonging survival of patients with low grade glioma however, remains controversial, largely because studies in the literature on the management of this disease have been predominantly descriptive and observational, which precludes the setting of standards for the management of these patients. Several viable management options are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10433109     DOI: 10.1023/a:1006103010109

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  69 in total

1.  Computed tomography in astrocytomas. A statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan.

Authors:  A R Butler; S C Horii; I I Kricheff; M B Shannon; G N Budzilovich
Journal:  Radiology       Date:  1978-11       Impact factor: 11.105

2.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

Authors:  C Daumas-Duport; M L Tucker; H Kolles; P Cervera; F Beuvon; P Varlet; N Udo; M Koziak; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

3.  Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.

Authors:  M C Chamberlain; J A Murovic; V A Levin
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

Review 4.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

5.  Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy.

Authors:  C A North; R B North; J A Epstein; S Piantadosi; M D Wharam
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

6.  Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients.

Authors:  P A Forsyth; E G Shaw; B W Scheithauer; J R O'Fallon; D D Layton; J A Katzmann
Journal:  Cancer       Date:  1993-08-15       Impact factor: 6.860

7.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Authors:  M S Berger; A V Deliganis; J Dobbins; G E Keles
Journal:  Cancer       Date:  1994-09-15       Impact factor: 6.860

8.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

9.  Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma.

Authors:  L D Lunsford; S Somaza; D Kondziolka; J C Flickinger
Journal:  J Neurosurg       Date:  1995-04       Impact factor: 5.115

10.  Treatment of low-grade cerebral astrocytoma: new methods and evaluation of results.

Authors:  J Koivukangas; P Koivukangas
Journal:  Ann Clin Res       Date:  1986
View more
  4 in total

1.  Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.

Authors:  G Çoban; S Mohan; F Kural; S Wang; D M O'Rourke; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-02       Impact factor: 3.825

Review 2.  Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.

Authors:  Ramon Francisco Barajas; Soonmee Cha
Journal:  CNS Oncol       Date:  2014-11

3.  Balancing maximal resection and functional preservation in surgery for low-grade glioma.

Authors:  Michael A Vogelbaum
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

4.  Gene expression analyses of grade II gliomas and identification of rPTPbeta/zeta as a candidate oligodendroglioma marker.

Authors:  Daniel Hägerstrand; Anja Smits; Anna Eriksson; Sunna Sigurdardottir; Tommie Olofsson; Magdalena Hartman; Monica Nistér; Hannu Kalimo; Arne Ostman
Journal:  Neuro Oncol       Date:  2007-11-14       Impact factor: 12.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.